Alembic Pharmaceuticals Alembic Pharmaceuticals is a company that manufactures branded formulations, international generics, and APIs (active pharmaceutical ingredients). | Cipla Cipla is a global pharmaceutical company, which develops and produces drugs for the treatment of arthritis, diabetes, weight control, depression, and cardiovascular diseases. | ||||
Founding Date | Founding Date 1988 | Founding Date 2018 | Founding Date 1907 | Founding Date 1928 | Founding Date 1935 |
Type | Type Private | Type Private | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations El Segundo, US HQ | Locations Vadodara, IN HQ Mumbai, IN Vadodara, IN | Locations Anderlecht, BE HQ Malvern, AU Wien, AT Braine L'alleud, BE São Paulo, BR Sofia, BG Oakville, CA see more | Locations Mumbai, IN HQ South Melbourne, AU Mumbai, IN Nairobi, KE Cape Town, ZA Durban, ZA Durban, ZA see more | |
Employees | Employees 489 | Employees 2 | Employees 14,858 | Employees 9,000 | Employees 27,7644% increase |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) ₹61.1b (FY, 2024) | Revenue (est.) €4.9b (FY, 2023) | Revenue (est.) ₹254.5b (FY, 2024) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods ₹19.3b (FY, 2024) | Cost of goods €1b (FY, 2023) | Cost of goods ₹88.2b (FY, 2024) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit ₹43b (FY, 2024) | Gross profit €4.8b (FY, 2023) | Gross profit ₹169.5b (FY, 2024) |
Net income | Net income N/A | Net income N/A | Net income ₹6.2b (FY, 2024) | Net income €343m (FY, 2023) | Net income ₹41.6b (FY, 2024) |